[Quantitative estimate of the risk of blood donation contamination by infectious agents]

J Pillonel1, C Brouard, S Laperche

  • 1Institut de Veille Sanitaire, 94415 Saint-Maurice cedex, France. j.pillonel@invs.sante.fr

Insights

Estimating transfusion-transmitted infections risk is crucial for blood safety. This study quantifies residual risks for major viral infections like HIV, HTLV, HCV, and HBV, aiding public health strategies.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Blood Transfusion Safety

Background:

  • Asymptomatic infectious agents in blood pose a transfusion transmission risk.
  • While HIV, HTLV, HCV, and HBV risks are controlled, others remain unquantified.
  • Outbreaks can temporarily increase transfusion-transmitted infection risks.

Purpose of the Study:

  • To update residual risk estimates for major transfusion-transmitted viral infections (HIV, HTLV, HCV, HBV).
  • To present work on quantifying contamination risks for blood donations.
  • To provide data for adapting prevention measures to transfusion risks.

Main Methods:

  • Utilizing quantitative risk estimation models.
  • Analyzing incidence and spatio-temporal distribution of infectious agents.
  • Updating previous risk assessments for key viral pathogens.

Main Results:

  • Provides updated quantitative estimates of residual transfusion risks.
  • Documents the methodology for risk assessment of blood donation contamination.
  • Highlights the importance of risk-based prevention strategies.

Conclusions:

  • Accurate risk quantification is essential for effective blood safety policies.
  • Updated estimates improve the management of transfusion-transmitted infection risks.
  • This work supports evidence-based decision-making in blood product safety.

Related Concept Videos

Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...